Tag: Vaccine

Responding to questions during the fifth episode of Sunday Samvaad, Union Health Minister, Dr Harsh Vardhan stated that emergency use authorization for COVID vaccine will depend on clinical trial data generated. He also revealed that the rollout of FELUDA Test expected in the next few weeks..........................

The Computational Biology Department at IIIT Delhi has reviewed different Covid-19 vaccines and has come up with several probable solutions to overcome the challenges faced by the doctors, genetic engineers, and epidemiologists in developing a viable vaccine for the virus......................

The company provides reefer vehicles (cold chain) services to the vaccine sector to ensure seamless transport of shipment. Has the capability to handle various temperature requirements- Frozen: -80◦C to -20◦C | Deep Chilled: 2◦C to 8◦C | Ambient: 15 ◦C to 25 ◦C..................

Acknowledging the challenges rabies poses – marred often by the lack of awareness people have about its symptoms and fatality for humans and animals alike – is of paramount importance, writes Varda Mehrotra.....................

The collaboration between the Serum Institute of India, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation will accelerate manufacturing and delivery of up to an additional 100 million doses of future safe and effective COVID-19 vaccines, priced at a maximum of US$ 3 per dose, for low- and middle-income countries in 2021..................

The residents in India can now virtually book an appointment for the vaccine in nearby clinics....................

The vaccines for SARS-CoV-2 being developed at the three institutes affiliated to the Council of Scientific and Industrial Research (CSIR) will be commercialized by Aurobindo Pharma Limited in India..................

Triple-antigen COVID-19 vaccine candidate, PRAK-03202, produces neutralizing immune response in animal studies; Premas Biotech in talks with regulatory authorities for next steps................

HMD has received an order from UNICEF to increase its supply of immunization AD syringes to the organization to around 300 million to build up a stockpile of around 140 million syringes for Covid-19 by the end of the year..................

In India, SCHOTT’s 50-50 joint venture, SCHOTT KAISHA is supplying vials for COVID-19 vaccines to Serum Institute (India) and several other players...............